Expression of circular RNA CDR1‑AS in colon cancer cells increases cell surface PD‑L1 protein levels

Tanaka,Eri; Miyakawa,Yu; Kishikawa,Takahiro; Seimiya,Takahiro; Iwata,Takuma; Funato,Kazuyoshi; Odawara,Nariaki; Sekiba,Kazuma; Yamagami,Mari; Suzuki,Tatsunori; Ishibashi,Rei; Otsuka,Motoyuki; Koike,Kazuhiko

doi:10.3892/or.2019.7244

Expression of circular RNA CDR1‑AS in colon cancer cells increases cell surface PD‑L1 protein levels

Authors:
- Eri Tanaka
- Yu Miyakawa
- Takahiro Kishikawa
- Takahiro Seimiya
- Takuma Iwata
- Kazuyoshi Funato
- Nariaki Odawara
- Kazuma Sekiba
- Mari Yamagami
- Tatsunori Suzuki
- Rei Ishibashi
- Motoyuki Otsuka
- Kazuhiko Koike
View Affiliations

Affiliations: Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo 113‑8655, Japan
Published online on: July 19, 2019 https://doi.org/10.3892/or.2019.7244
Pages: 1459-1466

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The expression of CDR1‑AS, a representative circular RNA, is closely linked with poor prognosis in gastrointestinal cancers, such as colon, liver, and pancreatic cancers. Although it is well known that CDR1‑AS antagonizes microRNA‑7 function through its sequence similarities in the brain, its biological function and link with the malignant potential of cancer cells remain unclear, partly due to the difficulties of ectopic expression of circular RNAs. In the present study, SW620, a colon cancer cell line that stably expresses CDR1‑AS RNA circularized, was established using the laccase 2 gene cassette, and its biological function associated with malignant behavior was determined. In contrast to previous studies, cell growth or invasion ability was not altered by CDR1‑AS expression. However, the expression levels of CMTM4 and CMTM6, which were recently recognized as critical regulators of PD‑L1 protein expression at the cell surface, were significantly increased. Accordingly, the cell surface PD‑L1 protein levels were increased in CDR1‑AS‑expressing cells. Notably, the effects were not canceled out by overexpressing microRNA‑7, indicating that the increase in cell surface PD‑L1 in CDR1‑AS‑expressing cells was not dependent on microRNA‑7 function. These results indicated that expression of this circular RNA in cancer cells may lead to poor prognosis by increasing cell surface PD‑L1 levels through microRNA‑7‑independent mechanisms.

View Figures

View References

1	Tay Y, Rinn J and Pandolfi PP: The multilayered complexity of ceRNA crosstalk and competition. Nature. 505:344–352. 2014. View Article : Google Scholar : PubMed/NCBI
2	Ebbesen KK, Hansen TB and Kjems J: Insights into circular RNA biology. RNA Biol. 14:1035–1045. 2017. View Article : Google Scholar : PubMed/NCBI
3	Kristensen LS, Hansen TB, Venø MT and Kjems J: Circular RNAs in cancer: Opportunities and challenges in the field. Oncogene. 37:555–565. 2018. View Article : Google Scholar : PubMed/NCBI
4	Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global patterns and trends in colorectal cancer incidence and mortality. Gut. 66:683–691. 2017. View Article : Google Scholar : PubMed/NCBI
5	Weng W, Wei Q, Toden S, Yoshida K, Nagasaka T, Fujiwara T, Cai S, Qin H, Ma Y and Goel A: Circular RNA ciRS-7-A promising prognostic biomarker and a potential therapeutic target in colorectal cancer. Clin Cancer Res. 23:3918–3928. 2017. View Article : Google Scholar : PubMed/NCBI
6	Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function as efficient microRNA sponges. Nature. 495:384–388. 2013. View Article : Google Scholar : PubMed/NCBI
7	Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer M, et al: Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
8	Horsham JL, Ganda C, Kalinowski FC, Brown RA, Epis MR and Leedman PJ: MicroRNA-7: A miRNA with expanding roles in development and disease. Int J Biochem Cell Biol. 69:215–224. 2015. View Article : Google Scholar : PubMed/NCBI
9	Kishikawa T, Otsuka M, Yoshikawa T, Ohno M, Yamamoto K, Yamamoto N, Kotani A and Koike K: Quantitation of circulating satellite RNAs in pancreatic cancer patients. JCI Insight. 1:e866462016. View Article : Google Scholar : PubMed/NCBI
10	Yamagami M, Otsuka M, Kishikawa T, Sekiba K, Seimiya T, Tanaka E, Suzuki T, Ishibashi R, Ohno M and Koike K: ISGF3 with reduced phosphorylation is associated with constitutive expression of interferon-induced genes in aging cells. NPJ Aging Mech Dis. 4:112018. View Article : Google Scholar : PubMed/NCBI
11	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
12	Sekiba K, Yamagami M, Otsuka M, Suzuki T, Kishikawa T, Ishibashi R, Ohno M, Sato M and Koike K: Transcriptional activation of the MICA gene with an engineered CRISPR-Cas9 system. Biochem Biophys Res Commun. 486:521–525. 2017. View Article : Google Scholar : PubMed/NCBI
13	Yoshikawa T, Wu J, Otsuka M, Kishikawa T, Suzuki N, Takata A, Ohno M, Ishibashi R, Yamagami M, Nakagawa R, et al: Repression of MicroRNA function mediates inflammation-associated colon tumorigenesis. Gastroenterology. 152:631–643. 2017. View Article : Google Scholar : PubMed/NCBI
14	Agarwal V, Bell GW, Nam JW and Bartel DP: Predicting effective microRNA target sites in mammalian mRNAs. Elife. 4:2015. View Article : Google Scholar
15	Kramer MC, Liang D, Tatomer DC, Gold B, March ZM, Cherry S and Wilusz JE: Combinatorial control of Drosophila circular RNA expression by intronic repeats, hnRNPs, and SR proteins. Genes Dev. 29:2168–2182. 2015. View Article : Google Scholar : PubMed/NCBI
16	Zhang N, Li X, Wu CW, Cai M, Mok MT, Wang H, Chen J, Ng SS, Chen M, Sung JJ and Yu J: microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis. Oncogene. 32:5078–5088. 2013. View Article : Google Scholar : PubMed/NCBI
17	Peng L, Yuan XQ and Li GC: The emerging landscape of circular RNA ciRS-7 in cancer (Review). Oncol Rep. 33:2669–2674. 2015. View Article : Google Scholar : PubMed/NCBI
18	Mezzadra R, Sun C, Jae LT, Gomez-Eerland R, de Vries E, Wu W, Logtenberg MEW, Slagter M, Rozeman EA, Hofland I, et al: Identification of CMTM6 and CMTM4 as PD-L1 protein regulators. Nature. 549:106–110. 2017. View Article : Google Scholar : PubMed/NCBI
19	Burr ML, Sparbier CE, Chan YC, Williamson JC, Woods K, Beavis PA, Lam EYN, Henderson MA, Bell CC, Stolzenburg S, et al: CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity. Nature. 549:101–105. 2017. View Article : Google Scholar : PubMed/NCBI
20	Chen DS, Irving BA and Hodi FS: Molecular pathways: Next-generation immunotherapy-inhibiting programmed death-ligand 1 and programmed death-1. Clin Cancer Res. 18:6580–6587. 2012. View Article : Google Scholar : PubMed/NCBI
21	Tang W, Ji M, He G, Yang L, Niu Z, Jian M, Wei Y, Ren L and Xu J: Silencing CDR1as inhibits colorectal cancer progression through regulating microRNA-7. Onco Targets Ther. 10:2045–2056. 2017. View Article : Google Scholar : PubMed/NCBI
22	Zhang J, Hu H and Zhao Y and Zhao Y: CDR1as is overexpressed in laryngeal squamous cell carcinoma to promote the tumour's progression via miR-7 signals. Cell Prolif. 51:e125212018. View Article : Google Scholar : PubMed/NCBI